HHS Unveils Sweeping Plan to Combat Lyme Disease and Advance Treatment
Clinical Scorecard: HHS Launches Comprehensive Strategy to Address Lyme Disease and Enhance Treatment Options
At a Glance
| Category | Detail |
|---|
| Condition | Lyme disease and other tick-borne illnesses |
| Key Mechanisms | Tick control, research funding, innovation challenges |
| Target Population | Americans diagnosed with Lyme disease and Alpha-gal syndrome |
| Care Setting | Public-private collaborations, community health initiatives |
Key Highlights
- Over 476,000 Americans diagnosed with Lyme disease annually
- New multi-million-dollar pilot program for tick control
- Goal to reduce Lyme disease cases by 25% by 2035
- LymeX innovation challenges offering up to $2.5 million in funding
- Collaboration with ILADS for patient-provider connections
Guideline-Based Recommendations
Diagnosis
- Accelerate development of faster, more accurate Lyme disease tests
Management
- Public-private collaboration to improve patient care and access to providers
Monitoring & Follow-up
- Ongoing research into Lyme disease and tick-borne illnesses
Risks
- Potential allergic reactions from Alpha-gal syndrome
Patient & Prescribing Data
Individuals diagnosed with Lyme disease and Alpha-gal syndrome
Focus on innovative treatments and improved diagnostics
Clinical Best Practices
- Engage in community collaboration for tick control
- Utilize clinician locator tools for patient access
- Support ongoing research and innovation in treatment options
Related Resources & Content
